More Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A news
Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class ASSE: 688621

"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on Progress of Cooperative Investment with Private Fund

Sep 15, 2026 · Issued by Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Progress of Cooperative Investment with Private Fund

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A

  • "Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on the Use of Certain Raised Funds to Increase the Capital of a Wholly-owned Subsidiary for the Implementation of Fundraising Investment ProjectsAug 29
  • "Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on Vesting Results for the 1st Vesting Period of the Initial Grant under the 2025 Restricted Share Incentive PlanAug 13
  • "Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on Voluntary Disclosure of External InvestmentJul 29
  • "Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jul 21
All Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A news releases↗